SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : North American Vaccine
NVX 1.425-4.7%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Don W Stone who wrote (344)3/31/1998 3:12:00 PM
From: Don W Stone  Read Replies (1) of 507
 
Last week it was announced that Dr. Prem Lachman of Goldman Sachs was leaving the firm to start his own Fund.
Yesterday , it was on the Dow that Goldman was dropping coverage of the companies that Prem Lachman followed to include NVX , ABT and several other drug companies.

Hopefully, with FDA approval, we will see some other firms start to follow NVX. I think it highly probable. We'll see. :-}

Who knows, maybe Dr. Lachman's fund will become a big stockholder of NVX. Now that does make a lot of sense to me.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News